Protective, anti-tumor monoclonal antibody recognizes a conformational epitope similar to melibiose at the surface of invasive murine melanoma cells

Hybridoma and Hybridomics

Volumn 21, Issue 5, 2002, Pages 321-331

  Dobroff, A S ^a   Rodrigues, E G ^a   Moraes, J Z ^a   Travassos, Luiz R ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSIDASE; CARBOHYDRATE; EPITOPE; GALACTOSE; GLUTARALDEHYDE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; LACTOSE; MANNOSE; MELAN A; MELIBIOSE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY A4; MONOCLONAL ANTIBODY B11; MUCIN; POLYCLONAL ANTIBODY; RAFFINOSE; SIALIC ACID; UNCLASSIFIED DRUG;

ACCURACY; ANIMAL CELL; ANIMAL MODEL; ANTIBODY AFFINITY; ANTIGEN ANTIBODY REACTION; ANTIGEN BINDING; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INVASION; CELL PROTECTION; CELL SURFACE; CHEMOLUMINESCENCE; CONFORMATION; CONTROLLED STUDY; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME THERAPY; FEMALE; MALE; MELANOMA CELL; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; POLYCLONAL ACTIVATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTOZOON; TUMOR CELL;

ANIMALIA; MURINAE; PROTOZOA;

EID: 0036936897     PISSN: 15368599     EISSN: None     Source Type: Journal    
DOI: 10.1089/153685902761022661     Document Type: Article

References (21)

1. Varki A, Cummings R, Esko J, Freeze H, Hart G, and Marth J: Essentials of Glycobiology; Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1999.
2. Houghton AN, and Coit DG: Therapy of metastatic melanoma with monoclonal antibodies. New Perspect Cancer Diagn Manage 1993;1:65-70.
3. Pukel CS, Lloyd KO, Travassos LR, Dippold WG, Oettgen HF, and Old LJ: GD3, a prominent ganglioside of human melanoma. Detection and characterization of a mouse monoclonal antibody. J Exp Med 1982;155:1133-1147.
4. Houghton AN, Mintzer D, Cordon-Cardo C, Welt S, Fliegel B, Vadhan S, Carswell E, Melamed MR, Oettgen HF, and Old LJ: Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: A phase I trial in patients with malignant melanoma. Proc Natl Acad Sci USA 1985;82:1242-1246.
5. Vazquez AM, Gabri MR, Hernandez AM, Alonso DF, Beausoleil I, Gomez DE, and Perez R: Antitumor properties of an anti-idiotypic monoclonal antibody in relation to N-glycolyl-containing gangliosides: Oncol Rep 2000;7:751-756.
6. Carr A, Mullet A, Mazorra Z, Vazquez AM, Alfonso M, Mesa C, Rengifo E, Perez R, and Fernandez LE: A mouse IgG1 monoclonal antibody specific for N-glycolyl GM3 ganglioside recognized breast and melanoma tumors. Hybridoma 2000;19:241-247.
7. Law LW, Vieira WD, Hearing VJ, and Gersten DM: Further studies of the therapeutic effects of murine melanoma-specific monoclonal antibodies. Biochim Biophys Acta 1994;1226:105-109.
8. Gersten DM, Moody D, Vieira WD, Law LW, and Hearing VJ: Production of monoclonal antibodies against the B700 murine melanoma antigen and their antimetastatic properties. Biochim Biophys Acta 1992;1138:109-114.
9. Xu X, Azumi N, Skelton HG, Hearing VJ, and Gersten DM: Immunostaining of human melanomas by a monoclonal antibody to B700 mouse melanoma antigen. Eur J Cancer 1996;32A:168-173.
10. Toporowicz A, Gersten DM, Hearing VJ, Brown WE, and Vlock DR: Cross-reactivity between murine melanoma antigen B700 and a human melanoma-associated antigen (M-66) recognized by autologous antibody: Evidence suggesting shared epitopes. Biochim Biophys Acta 1993;1182:51-56.
11. Almeida IC, Covas DT, Soussumi LMT, and Travassos LR: A highly sensitive and specific chemiluminescent enzyme-linked immunosorbent assay for diagnosis of active Trypanosorna cruzi infection. Transfusion 1997;37:850-857.
12. Galili U, Anaraki F, Thall A, Hill-Black C, and Radic M: One percent of human circulating B lymphocytes are capable of producing the natural anti-Gal antibody. Blood 1993;82:2485-2493.
13. Galili U, Shohet SB, Kobrin E, Stults CL, and Macher BA: Man, apes, and Old World monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells. J Biol Chem 1988;263:17755-17762.
14. Lloyd KO, Travassos LR, Takahashi T, and Old LJ: Cell surface glycoproteins of human tumor cell lines: Unusual characteristics of malignant melanoma. J Nat Cancer Inst 1979;63:623-634.
15. α-galactosyl antibodies from patients with chronic Chagas' disease recognize novel O-linked oligosaccharides on mucin-like glycosyl-phosphatidylinositol-anchored glycoproteins of Trypanosorna cruzi. Biochem J 1994;304:793-802.
16. Apostolopoulos V, Sandrin MS, and McKenzie IFC: Carbohydrate/peptide mimics: Effect on MUC1 cancer immunotherapy. J Mol Med 1999;77:427-436.
17. α(1,3)Gal-binding proteins. Xenotransplantation 1996;3:18-23.
18. Sandrin MS, Vaughan HA, Xing PX, and McKenzie IF: Natural human anti-Gal alpha (1,3) Gal antibodies react with human mucin peptides. Glycoconj J 1997;14:97-105.
19. Seliger B, Wollscheid U, Momburg F, Blankenstein T, and Huber C: Characterization of the major histocompatibility complex class I deficiencies in B16 melanoma cells. Cancer Res 2001;61:1095-1099.
20. Shockley TR, Lin K, Nagy JA, Tomkins RG, Yarmush ML, and Dvorak HF: Spatial distribution of tumor-specific monoclonal antibodies in human melanoma xenografts. Cancer Res 1992;52:367-376.
21. Lin K, Nagy JA, Xu H, Schockley TR, Yarmush ML, and Dvorak HF: Compartmental distribution of tumor-specific monoclonal antibodies in human melanoma xenografts. Cancer Res 1994;54:2269-2277.